Can the BNP Peptide Measured During a Heart Attack Predict Who Will Develop Heart Failure Later? | Research

The takeaway

Higher baseline BNP levels during acute coronary syndrome are associated with later heart failure development, but a single BNP measurement alone is not a reliable predictor.

SMD = 0.95 (p<0.001)
Heart failure patients had significantly higher baseline BNP levels during their acute coronary event, but the wide variation limits individual prediction

What the researchers found

Across 10 studies, the meta-analysis found:

- Patients who developed heart failure post-ACS had significantly higher baseline BNP levels (standardized mean difference: 0.95, 95% CI: 0.54–1.37, p<0.001)

- However, the odds ratio for HF occurrence based on baseline BNP was not significant (OR: 1.83, 95% CI: 0.11–29.07, p=0.67)

- 8 of 10 individual studies showed a positive association between baseline BNP and post-ACS heart failure

This discrepancy suggests that while BNP is elevated in those who develop HF, the variation between studies is too large for a single cutoff to be clinically useful.

Why it matters

Heart failure after a heart attack is common and deadly, but early identification of at-risk patients could allow preventive treatment. BNP is already routinely measured in cardiac care. If baseline BNP could reliably predict post-ACS heart failure, it would require no additional testing — just better use of existing data. This study clarifies that while BNP is informative, it needs to be part of a broader risk assessment strategy.

How the study worked

Systematic review and meta-analysis of 10 studies identified from Medline database. Included studies reported baseline BNP values in ACS patients and subsequent heart failure incidence. Both odds ratios (for categorical BNP analysis) and standardized mean differences (for continuous BNP values) were calculated. Statistical analysis was performed using Review Manager.

What this study cannot tell us

Only 10 studies met inclusion criteria, limiting statistical power. The wide confidence interval for the odds ratio (0.11–29.07) indicates extreme heterogeneity. Different BNP assays, cutoff values, and follow-up durations across studies may explain inconsistent results. Only Medline was searched, potentially missing relevant studies in other databases. The distinction between BNP and NT-proBNP across studies was not addressed in the abstract.

How to read the evidence

This is a systematic review and meta-analysis of 10 observational studies. While the study design is appropriate, the very high heterogeneity and non-significant odds ratio limit the strength of the conclusion for clinical prediction.

When this study was published

Published in 2025, this meta-analysis provides a current synthesis of the evidence for BNP-based prediction of post-ACS heart failure.

The bigger picture

BNP and NT-proBNP are among the most widely used peptide biomarkers in cardiology, central to heart failure diagnosis and management guidelines. This meta-analysis extends the question to prognostication: can these peptides predict heart failure before it develops? The finding that BNP is associated but not individually predictive highlights a broader challenge in biomarker research — the gap between statistical association and clinical utility.

Questions still open

Would serial BNP measurements (at admission, discharge, and follow-up) improve predictive accuracy for post-ACS heart failure?
Can BNP be combined with echocardiographic parameters and other biomarkers into a composite risk score?
Do different ACS subtypes (STEMI vs. NSTEMI) require different BNP thresholds for heart failure prediction?

Common questions

What is BNP and why is it measured during heart attacks?

Brain natriuretic peptide (BNP) is a small hormone released by heart muscle cells when they are stretched or stressed — typically when the heart is struggling to pump effectively. Measuring BNP levels through a simple blood test helps doctors assess how much strain the heart is under. Higher levels indicate greater cardiac stress and are a hallmark of heart failure.

If BNP levels are elevated, does that mean heart failure is inevitable?

No. This study found that while elevated BNP during a heart attack is associated with a higher chance of developing heart failure later, many patients with high BNP do not develop heart failure, and some with lower levels do. BNP is one piece of the puzzle — doctors should combine it with other tests, imaging, and clinical factors for a more complete picture.

Read the original research

Evaluating the Role of Baseline Brain Natriuretic Peptide in Predicting Heart Failure Post-acute Coronary Syndrome: Systematic Review and Meta-analysis.

Heart views : the official journal of the Gulf Heart Association, 26(2), 116-125

View on PubMed ↗Publisher’s paper ↗

Citation

Kusumowardani, Alivia Retra; Yudhisthira, Narendra Lintang. (2025). Evaluating the Role of Baseline Brain Natriuretic Peptide in Predicting Heart Failure Post-acute Coronary Syndrome: Systematic Review and Meta-analysis.. Heart views : the official journal of the Gulf Heart Association, 26(2), 116-125. https://doi.org/10.4103/heartviews.heartviews_125_24